SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 43 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $21,000 | -19.2% | 78,673 | +514.0% | 0.00% | -50.0% |
| Q3 2018 | $26,000 | +420.0% | 12,813 | +454.9% | 0.00% | – |
| Q2 2018 | $5,000 | -68.8% | 2,309 | -72.6% | 0.00% | -100.0% |
| Q3 2017 | $16,000 | +60.0% | 8,442 | +263.3% | 0.00% | 0.0% |
| Q1 2017 | $10,000 | -63.0% | 2,324 | -69.0% | 0.00% | -66.7% |
| Q4 2016 | $27,000 | – | 7,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 7,600,000 | $9,234,000 | 7.03% |
| Samsara BioCapital, LLC | 3,750,000 | $4,556,000 | 3.58% |
| CAXTON CORP | 277,245 | $337,000 | 0.31% |
| BVF INC/IL | 2,287,860 | $2,780,000 | 0.31% |
| Eventide Asset Management | 5,965,455 | $7,248,000 | 0.25% |
| Telemetry Investments, L.L.C. | 197,564 | $240,000 | 0.12% |
| NEA Management Company, LLC | 1,298,274 | $1,584,000 | 0.08% |
| RP Management, LLC | 129,517 | $158,000 | 0.08% |
| Palo Alto Investors LP | 1,162,473 | $1,412,000 | 0.06% |
| Fosun International Ltd | 725,000 | $863,000 | 0.06% |